United States Biotechnology & Medical Research

Agenus Inc (AGEN)

Track

Track

Agenus Inc has recorded no insider trading activity within the last three months. The most recent transactions occurred in February 2024, involving a purchase by Garo H. Armen. Historical records indicate various buying and selling patterns by company leadership, though these events predate the current quarter.
Ticker: AGEN Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Agenus Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.4
ARMEN GARO H See Remarks Executive Director
Transaction date
Purchase
Price
24.25
Quantity 86,180 -41.7%
Value US$4,896,087
3.4
WIINBERG ULF Non-Executive Director
Transaction date
Purchase
Price
229.71
Quantity 66,742 -0.8%
Value US$4,589,587
3.2
O'Day Steven J Chief Medical Officer Officer
Transaction date
Sale
Price
439.37
Quantity 88,536 +42.0%
Value US$1,813,479
2.4
ARMEN GARO H Chairman and CEO Executive Director
Transaction date
Sale
Price
6.50
Quantity 82,107 -9.6%
Value US$533,696
3.3
KLASKIN CHRISTINE M PFO & PAO Officer
Transaction date
Sale
Price
6.50
Quantity 11,120 -10.7%
Value US$72,280
1.5
INCYTE CORP Large shareholder
Transaction date
Sale
Price
3.66
Quantity 141,920 -0.8%
Value US$518,831
1.5
INCYTE CORP Large shareholder
Transaction date
Sale
Price
3.66
Quantity 72,080 -0.4%
Value US$264,007
1.5
INCYTE CORP Large shareholder
Transaction date
Sale
Price
3.57
Quantity 384,025 -2.2%
Value US$1,372,160
1.5
INCYTE CORP Large shareholder
Transaction date
Sale
Price
3.58
Quantity 9,100 -0.1%
Value US$32,556
1.5
INCYTE CORP Large shareholder
Transaction date
Sale
Price
3.77
Quantity 183,875 -1.0%
Value US$692,786
Baysal Ozer Chief Commercial Officer
Transaction date
Sale
Price
3.46
Quantity 3,712 -5.9%
Value US$12,846
Valentine Karen Chief Legal Officer
Transaction date
Sale
Price
3.46
Quantity 8,358 -7.6%
Value US$28,921
Duncan Alex Chief Technology Officer
Transaction date
Sale
Price
3.46
Quantity 6,546 -23.7%
Value US$22,651
Buell Jennifer Chief Communications Officer
Transaction date
Sale
Price
3.46
Quantity 3,511 -9.0%
Value US$12,152
KLASKIN CHRISTINE M VP, Finance
Transaction date
Sale
Price
3.46
Quantity 5,610 -8.0%
Value US$19,418
ARMEN GARO H Chairman & CEO Executive Director
Transaction date
Purchase
Price
3.29
Quantity 29,456 +2.1%
Value US$97,055
ARMEN GARO H Chairman & CEO Executive Director
Transaction date
Purchase
Price
3.37
Quantity 70,544 +5.4%
Value US$237,465
INCYTE CORP Large shareholder
Transaction date
Purchase
Price
6.00
Quantity 10,000,000 +128.8%
Value US$60,000,000
WIINBERG ULF Non-Executive Director
Transaction date
Purchase
Price
6.29
Quantity 30,000 +inf%
Value US$188,700
ARMEN GARO H Chairman & CEO Officer
Transaction date
Purchase
Price
3.28
Quantity 50,000 +3.7%
Value US$163,935
ARMEN GARO H Chairman & CEO Officer
Transaction date
Purchase
Price
3.08
Quantity 50,000 +3.9%
Value US$153,960
Baysal Ozer Chief Business Officer Officer
Transaction date
Purchase
Price
3.10
Quantity 2,250 +7.2%
Value US$6,975
ARMEN GARO H Chairman & CEO Officer
Transaction date
Purchase
Price
4.03
Quantity 200,000 +19.0%
Value US$805,600
ARMEN GARO H Chairman & CEO Officer
Transaction date
Sale
Price
4.57
Quantity 85,224 -6.6%
Value US$389,602
ARMEN GARO H Chairman & CEO Officer
Transaction date
Sale
Price
4.59
Quantity 89,917 -6.5%
Value US$413,142
ARMEN GARO H Chairman & CEO Officer
Transaction date
Sale
Price
4.62
Quantity 44,435 -3.1%
Value US$205,134
ARMEN GARO H Chairman & CEO Officer
Transaction date
Purchase
Price
5.03
Quantity 100,000 +7.6%
Value US$503,000
Ballantyne Charles Evan Chief Financial Officer Officer
Transaction date
Purchase
Price
5.05
Quantity 10,000 +inf%
Value US$50,500
Malik Shahzad Non-Executive Director
Transaction date
Sale
Price
7.02
Quantity 407,377 -100.0%
Value US$2,858,809
Malik Shahzad Non-Executive Director
Transaction date
Sale
Price
7.16
Quantity 700,000 -63.2%
Value US$5,012,560
QVT Associates GP LLC Large shareholder
Transaction date
Sale
Price
5.33
Quantity 41,830 -0.6%
Value US$222,954
QVT Associates GP LLC Large shareholder
Transaction date
Sale
Price
5.31
Quantity 83,100 -1.2%
Value US$441,261
QVT Associates GP LLC Large shareholder
Transaction date
Sale
Price
5.35
Quantity 100,000 -1.4%
Value US$535,000
QVT Associates GP LLC Large shareholder
Transaction date
Sale
Price
5.49
Quantity 89,800 -1.2%
Value US$493,002
QVT Associates GP LLC Large shareholder
Transaction date
Sale
Price
5.44
Quantity 50,000 -0.7%
Value US$272,000
QVT Associates GP LLC Large shareholder
Transaction date
Sale
Price
5.20
Quantity 100,000 -1.4%
Value US$520,000
QVT Associates GP LLC Large shareholder
Transaction date
Sale
Price
5.57
Quantity 43,080 -0.6%
Value US$239,956
QVT Associates GP LLC Large shareholder
Transaction date
Sale
Price
5.18
Quantity 856,920 -10.3%
Value US$4,438,846
QVT Associates GP LLC Large shareholder
Transaction date
Sale
Price
5.19
Quantity 215,000 -2.5%
Value US$1,115,850
QVT Associates GP LLC Large shareholder
Transaction date
Sale
Price
5.62
Quantity 400,000 -4.5%
Value US$2,248,000
QVT Associates GP LLC Large shareholder
Transaction date
Sale
Price
5.21
Quantity 53,606 -0.6%
Value US$279,287
QVT Associates GP LLC Large shareholder
Transaction date
Sale
Price
5.27
Quantity 146,394 -1.6%
Value US$771,496
QVT Associates GP LLC Large shareholder
Transaction date
Sale
Price
5.30
Quantity 143,900 -1.6%
Value US$762,670
QVT Associates GP LLC Large shareholder
Transaction date
Sale
Price
5.55
Quantity 20,000 -0.2%
Value US$111,000
Wentworth Kerry VP, Clinical, Reg, & Quality Officer
Transaction date
Sale
Price
2.01
Quantity 8,939 -36.6%
Value US$17,967
Valentine Karen VP, General Counsel Officer
Transaction date
Sale
Price
1.98
Quantity 7,605 -86.5%
Value US$15,058
Sharp Shalini CFO Officer
Transaction date
Sale
Price
2.09
Quantity 1,711 -3.9%
Value US$3,576
Wentworth Kerry VP, Clinical, Reg, & Quality Officer
Transaction date
Sale
Price
2.09
Quantity 1,893 -7.2%
Value US$3,956
Valentine Karen VP, General Counsel Officer
Transaction date
Sale
Price
2.09
Quantity 1,301 -12.9%
Value US$2,719
Sharp Shalini CFO Officer
Transaction date
Sale
Price
2.14
Quantity 2,853 -6.2%
Value US$6,105
KLASKIN CHRISTINE M VP, Finance Officer
Transaction date
Sale
Price
2.14
Quantity 1,824 -12.6%
Value US$3,903
Wentworth Kerry VP, Clinical, Reg, & Quality Officer
Transaction date
Sale
Price
2.14
Quantity 3,156 -10.7%
Value US$6,754
Valentine Karen VP, General Counsel Officer
Transaction date
Sale
Price
2.14
Quantity 2,169 -17.7%
Value US$4,642
KLASKIN CHRISTINE M VP Finance Officer
Transaction date
Sale
Price
2.20
Quantity 511 -3.4%
Value US$1,123
Wentworth Kerry VP, Clinical, Reg, & Quality Officer
Transaction date
Sale
Price
2.20
Quantity 886 -2.9%
Value US$1,947
Valentine Karen VP, General Counsel Officer
Transaction date
Sale
Price
2.20
Quantity 608 -4.7%
Value US$1,336
Sharp Shalini CFO Officer
Transaction date
Sale
Price
2.20
Quantity 795 -1.7%
Value US$1,747
KLASKIN CHRISTINE M VP Finance Officer
Transaction date
Sale
Price
2.19
Quantity 993 -6.2%
Value US$2,175
Wentworth Kerry VP, Clinical, Reg, & Quality Officer
Transaction date
Sale
Price
2.19
Quantity 1,716 -5.4%
Value US$3,759
Valentine Karen VP, General Counsel Officer
Transaction date
Sale
Price
2.19
Quantity 1,177 -8.4%
Value US$2,578
Sharp Shalini CFO Officer
Transaction date
Sale
Price
2.19
Quantity 1,548 -3.2%
Value US$3,391
KLASKIN CHRISTINE M VP Finance Officer
Transaction date
Sale
Price
2.24
Quantity 1,975 -11.0%
Value US$4,420
Wentworth Kerry VP, Clinical, Reg, & Quality Officer
Transaction date
Sale
Price
2.24
Quantity 3,414 -9.6%
Value US$7,641
Valentine Karen VP, General Counsel Officer
Transaction date
Sale
Price
2.24
Quantity 2,348 -14.3%
Value US$5,255
Sharp Shalini CFO Officer
Transaction date
Sale
Price
2.24
Quantity 3,087 -6.0%
Value US$6,909
ARMEN GARO H Chairman & CEO Officer
Transaction date
Purchase
Price
2.99
Quantity 16,666 +1.9%
Value US$49,768
ARMEN GARO H Chairman & CEO Officer
Transaction date
Purchase
Price
0.51
Quantity 2,150,976 +67.7%
Value US$1,096,998
Wright Timothy Non-Executive Director
Transaction date
Purchase
Price
1.34
Quantity 10,000 +inf%
Value US$13,400
Valentine Karen VP and General Counsel Officer
Transaction date
Sale
Price
0.76
Quantity 29,039 -36.1%
Value US$22,006
ARMEN GARO H Chairman & CEO Officer
Transaction date
Purchase
Price
1.97
Quantity 25,000 +2.2%
Value US$49,250
HATSOPOULOS JOHN Non-Executive Director
Transaction date
Purchase
Price
0.37
Quantity 10,000 +22.2%
Value US$3,700
HATSOPOULOS JOHN Non-Executive Director
Transaction date
Purchase
Price
1.72
Quantity 3,000 +7.1%
Value US$5,160
HATSOPOULOS JOHN Non-Executive Director
Transaction date
Purchase
Price
1.71
Quantity 7,000 +20.0%
Value US$11,970
MARGARET EISEN Non-Executive Director
Transaction date
Purchase
Price
2.36
Quantity 15,000 +300.0%
Value US$35,348
ARMEN GARO H Chairman and CEO Officer
Transaction date
Purchase
Price
3.00
Quantity 1,166,667 +10.2%
Value US$3,500,001
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-02-15 2024-02-15 B Purchase
2.4
ARMEN GARO H

See Remarks

Executive Director
86,180 -41.7%
24.25
US$4,896,087 		86,180 -41.7% 24.25 US$4,896,087
2023-11-17 2023-11-15 B Purchase
3.4
WIINBERG ULF
Non-Executive Director
66,742 -0.8%
229.71
US$4,589,587 		66,742 -0.8% 229.71 US$4,589,587
2022-01-06 2022-01-06 S Sale
3.2
O'Day Steven J

Chief Medical Officer

Officer
88,536 +42.0%
439.37
US$1,813,479 		88,536 +42.0% 439.37 US$1,813,479
2021-09-14 2021-09-13 S Sale
2.4
ARMEN GARO H

Chairman and CEO

Executive Director
82,107 -9.6%
6.50
US$533,696 		82,107 -9.6% 6.50 US$533,696
2021-09-14 2021-09-10 S Sale
3.3
KLASKIN CHRISTINE M

PFO & PAO

Officer
11,120 -10.7%
6.50
US$72,280 		11,120 -10.7% 6.50 US$72,280
2020-06-18 2020-06-17 S Sale
1.5
INCYTE CORP
Large shareholder
141,920 -0.8%
3.66
US$518,831 		141,920 -0.8% 3.66 US$518,831
2020-06-18 2020-06-16 S Sale
1.5
INCYTE CORP
Large shareholder
72,080 -0.4%
3.66
US$264,007 		72,080 -0.4% 3.66 US$264,007
2020-06-15 2020-06-15 S Sale
1.5
INCYTE CORP
Large shareholder
384,025 -2.2%
3.57
US$1,372,160 		384,025 -2.2% 3.57 US$1,372,160
2020-06-15 2020-06-12 S Sale
1.5
INCYTE CORP
Large shareholder
9,100 -0.1%
3.58
US$32,556 		9,100 -0.1% 3.58 US$32,556
2020-06-15 2020-06-11 S Sale
1.5
INCYTE CORP
Large shareholder
183,875 -1.0%
3.77
US$692,786 		183,875 -1.0% 3.77 US$692,786
2017-12-14 2017-12-12 S Sale Baysal Ozer

Chief Commercial Officer
3,712 -5.9%
3.46
US$12,846 		3,712 -5.9% 3.46 US$12,846
2017-12-14 2017-12-12 S Sale Valentine Karen

Chief Legal Officer
8,358 -7.6%
3.46
US$28,921 		8,358 -7.6% 3.46 US$28,921
2017-12-14 2017-12-12 S Sale Duncan Alex

Chief Technology Officer
6,546 -23.7%
3.46
US$22,651 		6,546 -23.7% 3.46 US$22,651
2017-12-14 2017-12-12 S Sale Buell Jennifer

Chief Communications Officer
3,511 -9.0%
3.46
US$12,152 		3,511 -9.0% 3.46 US$12,152
2017-12-14 2017-12-12 S Sale KLASKIN CHRISTINE M

VP, Finance
5,610 -8.0%
3.46
US$19,418 		5,610 -8.0% 3.46 US$19,418
2017-04-12 2017-04-12 B Purchase ARMEN GARO H

Chairman & CEO

Executive Director
29,456 +2.1%
3.29
US$97,055 		29,456 +2.1% 3.29 US$97,055
2017-04-12 2017-04-10 B Purchase ARMEN GARO H

Chairman & CEO

Executive Director
70,544 +5.4%
3.37
US$237,465 		70,544 +5.4% 3.37 US$237,465
2017-02-14 2017-02-14 B Purchase INCYTE CORP Large shareholder
10,000,000 +128.8%
6.00
US$60,000,000 		10,000,000 +128.8% 6.00 US$60,000,000
2016-09-08 2016-09-06 B Purchase WIINBERG ULF Non-Executive Director
30,000 +inf%
6.29
US$188,700 		30,000 +inf% 6.29 US$188,700
2016-05-10 2016-05-09 B Purchase ARMEN GARO H

Chairman & CEO

Officer
50,000 +3.7%
3.28
US$163,935 		50,000 +3.7% 3.28 US$163,935
2016-05-10 2016-05-05 B Purchase ARMEN GARO H

Chairman & CEO

Officer
50,000 +3.9%
3.08
US$153,960 		50,000 +3.9% 3.08 US$153,960
2016-05-09 2016-05-05 B Purchase Baysal Ozer

Chief Business Officer

Officer
2,250 +7.2%
3.10
US$6,975 		2,250 +7.2% 3.10 US$6,975
2016-03-08 2016-03-07 B Purchase ARMEN GARO H

Chairman & CEO

Officer
200,000 +19.0%
4.03
US$805,600 		200,000 +19.0% 4.03 US$805,600
2015-12-30 2015-12-29 S Sale ARMEN GARO H

Chairman & CEO

Officer
85,224 -6.6%
4.57
US$389,602 		85,224 -6.6% 4.57 US$389,602
2015-12-30 2015-12-28 S Sale ARMEN GARO H

Chairman & CEO

Officer
89,917 -6.5%
4.59
US$413,142 		89,917 -6.5% 4.59 US$413,142
2015-12-30 2015-12-28 S Sale ARMEN GARO H

Chairman & CEO

Officer
44,435 -3.1%
4.62
US$205,134 		44,435 -3.1% 4.62 US$205,134
2015-09-29 2015-09-25 B Purchase ARMEN GARO H

Chairman & CEO

Officer
100,000 +7.6%
5.03
US$503,000 		100,000 +7.6% 5.03 US$503,000
2015-09-29 2015-09-25 B Purchase Ballantyne Charles Evan

Chief Financial Officer

Officer
10,000 +inf%
5.05
US$50,500 		10,000 +inf% 5.05 US$50,500
2015-04-30 2015-04-29 S Sale Malik Shahzad Non-Executive Director
407,377 -100.0%
7.02
US$2,858,809 		407,377 -100.0% 7.02 US$2,858,809
2015-04-30 2015-04-28 S Sale Malik Shahzad Non-Executive Director
700,000 -63.2%
7.16
US$5,012,560 		700,000 -63.2% 7.16 US$5,012,560
2015-01-13 2015-01-09 S Sale QVT Associates GP LLC Large shareholder
41,830 -0.6%
5.33
US$222,954 		41,830 -0.6% 5.33 US$222,954
2015-01-13 2015-01-09 S Sale QVT Associates GP LLC Large shareholder
83,100 -1.2%
5.31
US$441,261 		83,100 -1.2% 5.31 US$441,261
2015-01-13 2015-01-09 S Sale QVT Associates GP LLC Large shareholder
100,000 -1.4%
5.35
US$535,000 		100,000 -1.4% 5.35 US$535,000
2015-01-13 2015-01-09 S Sale QVT Associates GP LLC Large shareholder
89,800 -1.2%
5.49
US$493,002 		89,800 -1.2% 5.49 US$493,002
2015-01-13 2015-01-09 S Sale QVT Associates GP LLC Large shareholder
50,000 -0.7%
5.44
US$272,000 		50,000 -0.7% 5.44 US$272,000
2015-01-13 2015-01-09 S Sale QVT Associates GP LLC Large shareholder
100,000 -1.4%
5.20
US$520,000 		100,000 -1.4% 5.20 US$520,000
2015-01-13 2015-01-09 S Sale QVT Associates GP LLC Large shareholder
43,080 -0.6%
5.57
US$239,956 		43,080 -0.6% 5.57 US$239,956
2015-01-13 2015-01-09 S Sale QVT Associates GP LLC Large shareholder
856,920 -10.3%
5.18
US$4,438,846 		856,920 -10.3% 5.18 US$4,438,846
2015-01-13 2015-01-09 S Sale QVT Associates GP LLC Large shareholder
215,000 -2.5%
5.19
US$1,115,850 		215,000 -2.5% 5.19 US$1,115,850
2015-01-13 2015-01-09 S Sale QVT Associates GP LLC Large shareholder
400,000 -4.5%
5.62
US$2,248,000 		400,000 -4.5% 5.62 US$2,248,000
2015-01-13 2015-01-09 S Sale QVT Associates GP LLC Large shareholder
53,606 -0.6%
5.21
US$279,287 		53,606 -0.6% 5.21 US$279,287
2015-01-13 2015-01-09 S Sale QVT Associates GP LLC Large shareholder
146,394 -1.6%
5.27
US$771,496 		146,394 -1.6% 5.27 US$771,496
2015-01-13 2015-01-09 S Sale QVT Associates GP LLC Large shareholder
143,900 -1.6%
5.30
US$762,670 		143,900 -1.6% 5.30 US$762,670
2015-01-13 2015-01-09 S Sale QVT Associates GP LLC Large shareholder
20,000 -0.2%
5.55
US$111,000 		20,000 -0.2% 5.55 US$111,000
2011-12-29 2011-12-29 S Sale Wentworth Kerry

VP, Clinical, Reg, & Quality

Officer
8,939 -36.6%
2.01
US$17,967 		8,939 -36.6% 2.01 US$17,967
2011-12-29 2011-12-29 S Sale Valentine Karen

VP, General Counsel

Officer
7,605 -86.5%
1.98
US$15,058 		7,605 -86.5% 1.98 US$15,058
2011-12-29 2011-12-28 S Sale Sharp Shalini

CFO

Officer
1,711 -3.9%
2.09
US$3,576 		1,711 -3.9% 2.09 US$3,576
2011-12-29 2011-12-28 S Sale Wentworth Kerry

VP, Clinical, Reg, & Quality

Officer
1,893 -7.2%
2.09
US$3,956 		1,893 -7.2% 2.09 US$3,956
2011-12-29 2011-12-28 S Sale Valentine Karen

VP, General Counsel

Officer
1,301 -12.9%
2.09
US$2,719 		1,301 -12.9% 2.09 US$2,719
2011-12-29 2011-12-27 S Sale Sharp Shalini

CFO

Officer
2,853 -6.2%
2.14
US$6,105 		2,853 -6.2% 2.14 US$6,105
2011-12-29 2011-12-27 S Sale KLASKIN CHRISTINE M

VP, Finance

Officer
1,824 -12.6%
2.14
US$3,903 		1,824 -12.6% 2.14 US$3,903
2011-12-29 2011-12-27 S Sale Wentworth Kerry

VP, Clinical, Reg, & Quality

Officer
3,156 -10.7%
2.14
US$6,754 		3,156 -10.7% 2.14 US$6,754
2011-12-29 2011-12-27 S Sale Valentine Karen

VP, General Counsel

Officer
2,169 -17.7%
2.14
US$4,642 		2,169 -17.7% 2.14 US$4,642
2011-12-23 2011-12-23 S Sale KLASKIN CHRISTINE M

VP Finance

Officer
511 -3.4%
2.20
US$1,123 		511 -3.4% 2.20 US$1,123
2011-12-23 2011-12-23 S Sale Wentworth Kerry

VP, Clinical, Reg, & Quality

Officer
886 -2.9%
2.20
US$1,947 		886 -2.9% 2.20 US$1,947
2011-12-23 2011-12-23 S Sale Valentine Karen

VP, General Counsel

Officer
608 -4.7%
2.20
US$1,336 		608 -4.7% 2.20 US$1,336
2011-12-23 2011-12-23 S Sale Sharp Shalini

CFO

Officer
795 -1.7%
2.20
US$1,747 		795 -1.7% 2.20 US$1,747
2011-12-23 2011-12-22 S Sale KLASKIN CHRISTINE M

VP Finance

Officer
993 -6.2%
2.19
US$2,175 		993 -6.2% 2.19 US$2,175
2011-12-23 2011-12-22 S Sale Wentworth Kerry

VP, Clinical, Reg, & Quality

Officer
1,716 -5.4%
2.19
US$3,759 		1,716 -5.4% 2.19 US$3,759
2011-12-23 2011-12-22 S Sale Valentine Karen

VP, General Counsel

Officer
1,177 -8.4%
2.19
US$2,578 		1,177 -8.4% 2.19 US$2,578
2011-12-23 2011-12-22 S Sale Sharp Shalini

CFO

Officer
1,548 -3.2%
2.19
US$3,391 		1,548 -3.2% 2.19 US$3,391
2011-12-23 2011-12-21 S Sale KLASKIN CHRISTINE M

VP Finance

Officer
1,975 -11.0%
2.24
US$4,420 		1,975 -11.0% 2.24 US$4,420
2011-12-23 2011-12-21 S Sale Wentworth Kerry

VP, Clinical, Reg, & Quality

Officer
3,414 -9.6%
2.24
US$7,641 		3,414 -9.6% 2.24 US$7,641
2011-12-23 2011-12-21 S Sale Valentine Karen

VP, General Counsel

Officer
2,348 -14.3%
2.24
US$5,255 		2,348 -14.3% 2.24 US$5,255
2011-12-23 2011-12-21 S Sale Sharp Shalini

CFO

Officer
3,087 -6.0%
2.24
US$6,909 		3,087 -6.0% 2.24 US$6,909
2011-10-03 2011-09-30 B Purchase ARMEN GARO H

Chairman & CEO

Officer
16,666 +1.9%
2.99
US$49,768 		16,666 +1.9% 2.99 US$49,768
2011-08-17 2011-08-16 B Purchase ARMEN GARO H

Chairman & CEO

Officer
2,150,976 +67.7%
0.51
US$1,096,998 		2,150,976 +67.7% 0.51 US$1,096,998
2010-05-19 2010-05-18 B Purchase Wright Timothy Non-Executive Director
10,000 +inf%
1.34
US$13,400 		10,000 +inf% 1.34 US$13,400
2010-03-18 2010-03-16 S Sale Valentine Karen

VP and General Counsel

Officer
29,039 -36.1%
0.76
US$22,006 		29,039 -36.1% 0.76 US$22,006
2009-06-29 2009-06-25 B Purchase ARMEN GARO H

Chairman & CEO

Officer
25,000 +2.2%
1.97
US$49,250 		25,000 +2.2% 1.97 US$49,250
2009-02-25 2009-02-25 B Purchase HATSOPOULOS JOHN Non-Executive Director
10,000 +22.2%
0.37
US$3,700 		10,000 +22.2% 0.37 US$3,700
2008-09-05 2008-09-04 B Purchase HATSOPOULOS JOHN Non-Executive Director
3,000 +7.1%
1.72
US$5,160 		3,000 +7.1% 1.72 US$5,160
2008-09-05 2008-09-03 B Purchase HATSOPOULOS JOHN Non-Executive Director
7,000 +20.0%
1.71
US$11,970 		7,000 +20.0% 1.71 US$11,970
2008-05-20 2008-05-16 B Purchase MARGARET EISEN Non-Executive Director
15,000 +300.0%
2.36
US$35,348 		15,000 +300.0% 2.36 US$35,348
2008-01-11 2008-01-09 B Purchase ARMEN GARO H

Chairman and CEO

Officer
1,166,667 +10.2%
3.00
US$3,500,001 		1,166,667 +10.2% 3.00 US$3,500,001
Explore more

More insider trading research around Agenus Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America